AI Science Tracker

FluEmbed predicts H3N2 antigenic drift from sequence alone

University of Georgia · 11 Aug 2026 · biology

Discovery

FluEmbed predicts H3N2 antigenic drift from sequence alone

FluEmbed, a protein language model framework, predicted influenza A (H3N2) antigenicity from RNA sequence with Spearman correlations of 0.67 to 0.80 against hemagglutination inhibition titers. It outperformed Hamming, BLOSUM62 and phylogenetic baselines, and in-silico mutagenesis showed unconstrained mutations carry greater escape potential outside dominant lineages. Validation uses existing HI assay data and retrospective sequences; no new wet-lab tests were run.

Technology: FluEmbed (protein language model embeddings)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: FluEmbed predictions from H3N2 sequences were correlated with existing hemagglutination inhibition titers (Spearman 0.67-0.80) and compared with Hamming, BLOSUM62 and phylogenetic baselines, with in-silico mutagenesis for escape potential.
  • Still unknown: The abstract states no limitations and does not discuss generalization beyond H3N2 or beyond the data used; no wet-lab tests were run.
  • AI role: A protein language model framework predicted H3N2 antigenicity from RNA sequence.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1371/journal.pcbi.1014628&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.